Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Song, S. H
Right arrow Articles by Gray, T. A
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Management of type 2 diabetes and lipids: a critique of the NICE guidelines 2008

Soon H Song

Diabetes Centre, Northern General Hospital, Sheffield, UK, soon_song{at}hotmail.com

Trevor A Gray

Department of Clinical Chemistry, Northern General Hospital, Sheffield, UK

Type 2 diabetes and cardiovascular disease are leading causes of morbidity and mortality in the UK. Appropriate and effective management of these conditions and associated risk factors such as hyperlipidaemia are the cornerstones to improving general well being and health outcomes. In 2008, the National Institute for Health and Clinical Excellence (NICE) published guidelines on the management of type 2 diabetes (CG66) and lipid modification (CG67). This article aims to give a practical critique of the clinical management strategies recommended by these guidelines. Br J Diabetes vasc Dis 2009;9:69—74

Key Words: NICE guideline • type 2 diabetes • lipid modification

The British Journal of Diabetes & Vascular Disease, Vol. 9, No. 2, 69-74 (2009)
DOI: 10.1177/1474651409103867
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?